Status:
COMPLETED
Quality of Life After Laparoscopic Removal of Essure®
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Contraceptive Device; Complications
Quality of Life
Eligibility:
FEMALE
18+ years
Brief Summary
A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve qualit...
Eligibility Criteria
Inclusion
- women aged 18 years or more
- patients with Essure® sterilization device
- surgical removal of Essure® with bilateral salpingectomy by laparoscopy
Exclusion
- interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
- impaired lower-limb range of motion preventing positioning for surgery
- inability to understand information provided
- prisoner or under administrative supervision.
Key Trial Info
Start Date :
October 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 17 2023
Estimated Enrollment :
474 Patients enrolled
Trial Details
Trial ID
NCT03281564
Start Date
October 14 2017
End Date
October 17 2023
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, France, 69677